Neuroprotective effects of Canagliflozin: Lessons from aged genetically diverse UM‐HET3 mice

The aging brain is characterized by progressive increases in neuroinflammation and central insulin resistance, which contribute to neurodegenerative diseases and cognitive impairment. Recently, the Interventions Testing Program demonstrated that the anti‐diabetes drug, Canagliflozin (Cana), a sodium...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayarathne, Hashan S. M., Debarba, Lucas K., Jaboro, Jacob J., Ginsburg, Brett C., Miller, Richard A., Sadagurski, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282842/
https://www.ncbi.nlm.nih.gov/pubmed/35707855
http://dx.doi.org/10.1111/acel.13653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282842/
https://www.ncbi.nlm.nih.gov/pubmed/35707855
http://dx.doi.org/10.1111/acel.13653

Ejemplares similares